Trials / Completed
CompletedNCT03037489
A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients
An Open-Label, One-Arm Phase II Extension Study to Evaluate Safety and Tolerability of MIV-711 in Patients With Knee Joint Osteoarthritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Medivir · Industry
- Sex
- All
- Age
- 40 Years – 81 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicentre, open-label, one-arm Phase II extension study to evaluate the safety and tolerability of MIV-711 in patients with knee joint osteoarthritis (OA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MIV-711 | MIV-711 administered orally once daily |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-11-28
- Completion
- 2017-11-28
- First posted
- 2017-01-31
- Last updated
- 2019-03-18
- Results posted
- 2019-03-18
Locations
4 sites across 4 countries: Bulgaria, Georgia, Germany, Moldova
Source: ClinicalTrials.gov record NCT03037489. Inclusion in this directory is not an endorsement.